Full Name
Quan Sing Ng
 
 
Email
gmsquan@nus.edu.sg
 

Publications

Results 1-5 of 5 (Search time: 0.01 seconds).

Issue DateTitleAuthor(s)
12019Association of clinical factors with survival outcomes in laryngeal squamous cell carcinoma (LSCC).Fong, Pei Yuan; Tan, Sze Huey ; Lim, Darren Wan Teck ; Tan, Eng Huat ; Ng, Quan Sing ; Sommat, Kiattisa ; Tan, Daniel Shao Weng ; Ang, Mei Kim 
216-Jul-2021Complementary Sequential Circulating Tumor Cell (CTC) and Cell-Free Tumor DNA (ctDNA) Profiling Reveals Metastatic Heterogeneity and Genomic Changes in Lung Cancer and Breast CancerKong, Say Li; Liu, Xingliang; Tan, Swee Jin; Tai, Joyce A; Phua, Ler Yee; Poh, Huay Mei ; Yeo, Trifanny; Chua, Yong Wei; Haw, Yu Xuan; Ling, Wen Huan ; Ng, Raymond Chee Hui ; Tan, Tira J ; Loh, Kiley Wei Jen ; Tan, Daniel Shao-Weng ; Ng, Quan Sing ; Ang, Mei Kim ; Toh, Chee Keong; Lee, Yi Fang; Lim, Chwee Teck ; Lim, Tony Kiat Hon; Hillmer, Axel M; Yap, Yoon Sim ; Lim, Wan-Teck 
33-Dec-2018Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastasesTan, Wan-Ling ; Ng, Quan Sing ; Lim, Cindy; Tan, Eng Huat ; Toh, Chee Keong; Ang, Mei-Kim ; Kanesvaran, Ravindran ; Jain, Amit ; Tan, Daniel SW ; Lim, Darren Wan-Teck 
424-Dec-2018Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases (vol 18, 1198, 2018)Tan, Wan-Ling ; Ng, Quan Sing ; Lim, Cindy; Tan, Eng Huat ; Toh, Chee Keong; Ang, Mei-Kim ; Kanesvaran, Ravindran ; Jain, Amit ; Tan, Daniel SW ; Lim, Darren Wan-Teck 
51-Jun-2018Phase 1b Trial of Ficlatuzumab, a Humanized Hepatocyte Growth Factor Inhibitory Monoclonal Antibody, in Combination With Gefitinib in Asian Patients With NSCLCTan, Eng-Huat ; Lim, Wan-Teck ; Ahn, Myung-Ju; Ng, Quan-Sing ; Ahn, Jin Seok; Tan, Daniel Shao-Weng ; Sun, Jong-Mu; Han, May; Payumo, Francis C; Mckee, Krista; Yin, Wei; Credi, Marc; Agarwal, Shefali; Jac, Jaroslaw; Park, Keunchil